Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

While much of the focus of treatment of muscle injuries has been to control this inflammation ... Immobilization has been shown to be detrimental to healing muscle leading to joint stiffness and ...

Among elite football players, atrophy may persist in the quadriceps and gastrocnemius muscles 2 years after ACL surgery. Results highlight the importance of isolated muscle strengthening after ACL ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.

Researchers have widely used various animal and cellular models to gain a deeper understanding of the pathophysiological mechanisms of muscle atrophy and develop effective treatment strategies.

It is the first muscle-targeted treatment candidate to demonstrate ... improvement in a pivotal Phase 3 trial in spinal muscular atrophy (SMA). Myostatin, a member of the TGFβ superfamily of ...

When the nerves are damaged, communication between the nerves and muscles becomes disrupted. This results in significant muscle weakness, atrophy, and loss of function. The majority of neuromuscular ...

We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any therapeutics to target the root cause of geographic atrophy, an advanced form of dry AMD ...

Analytics company GlobalData has shared its optimism regarding the future of Novartis’ spinal muscular atrophy (SMA ... compared to other treatments on the market. These include Biogen ...